HALO logo
halo search icon
6185
CanSino Biologics, Inc. Class H

6185 · CanSino Biologics, Inc. Class H

29.48

HKD
-2.58 (-8.047%)
21/08/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

HK$12.85B

PE

256.10

EV/EBITDA

91.8

DIV Yield

0%

Payout Ratio

0%

MQV Rating

5Very Weak

As at 21/08/2026 12:00:00 AM

Price Chart

Description

CanSino Biologics, Inc. engages in the research and development, manufacturing, and sale of vaccines. It offers shingles, meningitis, polio, adenovirus, and tuberculosis vaccines. The company was founded by Xuan Liu, Xue Feng Yu, Tao Zhu, Dong Xu Qiu and Hui Hua Mao on January 13, 2009 and is headquartered in Tianjin, China.

  • All-Companies
  • All-Consensus
  • Big Candle
  • Consensus Cheap
  • HALO All
  • HALO Balance Sheet
  • HALO Consensus Value
  • Volume Spike

Key Fundamentals

EPS 3 yr Growth

-103.10%

EBITDA Margin

5.90%

Operating Cashflow

¥33m

Free Cash Flow Return

0.60%

ROIC

0.50%

Interest Coverage

1.10

Quick Ratio

3.20

Performance

52 weeks range

Low 19.22 - 56.55

Trade Value (12mth)

US$1,317,037.00

1 week

26.02%

1 month

34.82%

YTD

-8.3%

1 year

-34.76%

All time high

450.00

Additional Data

Shares Outstanding (Fully Diluted)

247m

HALO Sector

Healthcare

Next Company Report Date

30-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

CNY

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Neutral

Mqv Small

Neutral

Momentum

Price

Very Strong

Earnings

Very Weak

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Strong

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

Key Stakeholders

NameTitle
Xue Feng YuIndividual
Hui Hua MaoIndividual
Dong Xu QiuIndividual
Qiming Venture Partners Ltd.Subsidiary
Zhong Qi ShaoIndividual

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of CanSino Biologics, Inc. Class H (6185:HKG)?
Halo FAQ
The current share price of CanSino Biologics, Inc. Class H (6185:HKG) is HKDHK$29.48.
2
What is the 52-week high share price for CanSino Biologics, Inc. Class H (6185:HKG)?
Halo FAQ
The 52-week high share price for CanSino Biologics, Inc. Class H (6185:HKG) is HKDHK$56.55.
3
What is the 52-week low share price for CanSino Biologics, Inc. Class H (6185:HKG)?
Halo FAQ
The 52-week low share price for CanSino Biologics, Inc. Class H (6185:HKG) is HKDHK$19.22.
4
What is the dividend yield for CanSino Biologics, Inc. Class H (6185:HKG)?
Halo FAQ
CanSino Biologics, Inc. Class H (6185:HKG) does not pay a dividend.
5
What was CanSino Biologics, Inc. Class H (6185:HKG) last dividend payment?
Halo FAQ
The last dividend payment of CanSino Biologics, Inc. Class H (6185:HKG) is HKDHK$0.94.
6
What is the franking level for CanSino Biologics, Inc. Class H (6185:HKG)?
Halo FAQ
CanSino Biologics, Inc. Class H (6185:HKG) has a franking level of 0.00%.
7
In which sector is CanSino Biologics, Inc. Class H (6185:HKG) classified?
Halo FAQ
CanSino Biologics, Inc. Class H (6185:HKG) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for CanSino Biologics, Inc. Class H (6185:HKG)?
Halo FAQ
The current P/E ratio for CanSino Biologics, Inc. Class H (6185:HKG) is 256.10.